Cargando…
Pre-emptive and therapeutic adoptive immunotherapy for nasopharyngeal carcinoma: Phenotype and effector function of T cells impact on clinical response
Adoptive T cell therapy has emerged as a powerful strategy to treat human cancers especially haematological malignancies. Extension of these therapies to solid cancers remains a significant challenge especially in the context of defining immunological correlates of clinical responses. Here we descri...
Autores principales: | Smith, Corey, Lee, Victor, Schuessler, Andrea, Beagley, Leone, Rehan, Sweera, Tsang, Janice, Li, Vivian, Tiu, Randal, Smith, David, Neller, Michelle A., Matthews, Katherine K., Gostick, Emma, Price, David A., Burrows, Jacqueline, Boyle, Glen M., Chua, Daniel, Panizza, Benedict, Porceddu, Sandro V., Nicholls, John, Kwong, Dora, Khanna, Rajiv |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353921/ https://www.ncbi.nlm.nih.gov/pubmed/28344888 http://dx.doi.org/10.1080/2162402X.2016.1273311 |
Ejemplares similares
-
Ex vivo expansion of human T cells for adoptive immunotherapy using the novel Xeno-free CTS Immune Cell Serum Replacement
por: Smith, Corey, et al.
Publicado: (2015) -
Complete response to PD-1 blockade following EBV-specific T-cell therapy in metastatic nasopharyngeal carcinoma
por: Smith, Corey, et al.
Publicado: (2021) -
T‐cell adoptive immunotherapy for BK nephropathy in renal transplantation
por: Jahan, Sadia, et al.
Publicado: (2020) -
'Off-the-shelf’ allogeneic antigen-specific adoptive T-cell therapy for the treatment of multiple EBV-associated malignancies
por: Sinha, Debottam, et al.
Publicado: (2021) -
SARS-CoV-2-specific T cells generated for adoptive immunotherapy are capable of recognizing multiple SARS-CoV-2 variants
por: Panikkar, Archana, et al.
Publicado: (2022)